Status:
COMPLETED
Target Engagement and Response to Oxytocin
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
This study will measure whether the engagement of intranasal oxytocin with a brain target is related to effects on learning during a social cognition training program.
Detailed Description
The study will determine whether oxytocin (OT) administration 30 min before a training session enhances the learning of social information in the context of a social cognitive skills training (SCST) p...
Eligibility Criteria
Inclusion
- Schizophrenia or schizoaffective disorder
- stable on an antipsychotic medication
Exclusion
- positive pregnancy test history of head injury
Key Trial Info
Start Date :
January 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03245437
Start Date
January 4 2018
End Date
July 31 2024
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90073